ANAB: AnaptysBio, Inc. Stock

by  •  • Comments Off on ANAB: AnaptysBio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 574.60
Enterprise Value ($M) 849.45
Book Value ($M) 88.10
Book Value / Share 3.29
Price / Book 6.52
NCAV ($M) 42.55
NCAV / Share 1.59
Price / NCAV 13.50

Profitability (mra)
Return on Invested Capital (ROIC) -0.39
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.86

Liquidity (mrq)
Quick Ratio 10.87
Current Ratio 10.87

Balance Sheet (mrq) ($M)
Current Assets 406.83
Assets 452.39
Liabilities 364.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 17.16
Operating Income -157.07
Net Income -163.62
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -120.80
Cash from Investing 144.75
Cash from Financing -59.30

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Deep Track Capital, LP 7.67 49.76
02-14 13G/A Tang Capital Partners Lp 7.30 -25.80
02-14 13G/A Point72 Asset Management, L.P. 3.00 -62.88
02-13 13G/A Vanguard Group Inc 5.19 -22.33
01-26 13G/A BlackRock Inc. 6.80 -3.04

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 65,997 110,849 59.54
2024-04-17 42,608 297,067 14.34
2024-04-16 34,295 244,875 14.01
2024-04-15 39,348 267,275 14.72

(click for more detail)

Similar Companies
AMLX – Amylyx Pharmaceuticals, Inc. AMPH – Amphastar Pharmaceuticals, Inc.
AMRX – Amneal Pharmaceuticals, Inc. ANNX – Annexon, Inc.
APLS – Apellis Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io